방법 비교
선택한 방법을 나란히 검토하세요. 서로 다른 행은 강조 표시됩니다.
| 위마비 주요 증상 지수× | 과민성 대장 증후군에 대한 Rome IV 진단 기준× | |
|---|---|---|
| 분야 | 소화기학 | 소화기학 |
| 계열 | Process / pipeline | Process / pipeline |
| 기원 연도≠ | 2003 | 2016 |
| 창시자≠ | Revicki, D. A., Rentz, A. M., Dubois, D., et al. | Rome Foundation (multinational expert consensus) |
| 유형≠ | Self-report | Diagnostic Criteria |
| 원전≠ | Revicki, D. A., Rentz, A. M., Dubois, D., Kahrilas, P., Stanghellini, V., Talley, N. J., & Tack, J. (2003). Development and validation of a patient-assessed gastroparesis symptom severity index. Alimentary Pharmacology & Therapeutics, 18(1), 141–150. link ↗ | Mearin, F., Lacy, B. E., Chang, L., et al. (2016). Bowel disorders. Gastroenterology. Published online June 2016 by the Rome Foundation. link ↗ |
| 별칭≠ | GCSI | Rome IV IBS, Rome Criteria |
| 관련 | 4 | 4 |
| 요약≠ | The Gastroparesis Cardinal Symptom Index (GCSI) is a validated, patient-reported outcome measure specifically designed to assess symptom severity in gastroparesis. Developed by Revicki and colleagues in 2003, the GCSI captures the three cardinal symptom clusters of gastroparesis: nausea and vomiting, postprandial fullness, and early satiety, plus bloating and stomach distension. The 9-item questionnaire is responsive to treatment changes and is increasingly used in clinical trials and practice to monitor gastroparesis progression and therapy response. | The Rome IV criteria are the internationally accepted diagnostic standard for irritable bowel syndrome (IBS), published in 2016 by the Rome Foundation. These criteria define IBS as recurrent abdominal pain (≥1 day per week for ≥3 months) associated with altered bowel habits, without structural or biochemical abnormalities. IBS is subtyped into four patterns—IBS-constipation predominant (IBS-C), IBS-diarrhea predominant (IBS-D), IBS-mixed (IBS-M), and IBS-unclassified (IBS-U)—based on stool consistency patterns. |
| ScholarGate데이터셋 ↗ |
|
|